Relation of smoking status to serum levels of N-terminal probrain natriuretic peptide in middle-aged men without overt cardiovascular disease

American Journal of Cardiology

Volumn 106, Issue 10, 2010, Pages 1456-1460

  Otsuka, Toshiaki ^a   Kawada, Tomoyuki ^a   Seino, Yoshihiko ^b   Ibuki, Chikao ^b   Katsumata, Masao ^a   Kodani, Eitaro ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NIPPON MEDICAL SCHOOL CHIBA HOKUSOH HOSPITAL   (Japan)

^c NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; DIABETES MELLITUS; DYSLIPIDEMIA; EXERCISE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE HYPERTROPHY; HEART RATE; HUMAN; HYPERTENSION; IMPAIRED GLUCOSE TOLERANCE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; QUESTIONNAIRE; SELF REPORT; SMOKING CESSATION;

ADULT; CARDIOVASCULAR DISEASES; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; SMOKING;

EID: 78149467690     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.06.075     Document Type: Article

References (24)

1. 2+-ATPase gene Circ Res 71 1992 9 17
2. Y. Ogawa, K. Nakao, M. Mukoyama, K. Hosoda, G. Shirakami, H. Arai, Y. Saito, S. Suga, M. Jougasaki, and H. Imura Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats The ventricle is a major site of synthesis and secretion of brain natriuretic peptide Circ Res 69 1991 491 500
3. P. Kinnunen, O. Vuolteenaho, and H. Ruskoaho Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching Endocrinology 132 1993 1961 1970
4. A.S. Maisel, P. Krishnaswamy, R.M. Nowak, J. McCord, J.E. Hollander, P. Duc, T. Omland, A.B. Storrow, W.T. Abraham, A.H. Wu, P. Clopton, P.G. Steg, A. Westheim, C.W. Knudsen, A. Perez, R. Kazanegra, H.C. Herrmann, and P.A. McCullough Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure N Engl J Med 347 2002 161 167
5. M. Davis, E. Espiner, G. Richards, J. Billings, I. Town, A. Neill, C. Drennan, M. Richards, J. Turner, and T. Yandle Plasma brain natriuretic peptide in assessment of acute dyspnoea Lancet 343 1994 440 444
6. M.R. Cowie, A.D. Struthers, D.A. Wood, A.J. Coats, S.G. Thompson, P.A. Poole-Wilson, and G.C. Sutton Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care Lancet 350 1997 1349 1353
7. J.L. Januzzi, R. van Kimmenade, J. Lainchbury, A. Bayes-Genis, J. Ordonez-Llanos, M. Santalo-Bel, Y.M. Pinto, and M. Richards NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients: the International Collaborative of NT-proBNP Study Eur Heart J 27 2006 330 337
8. J.G. Lainchbury, E. Campbell, C.M. Frampton, T.G. Yandle, M.G. Nicholls, and A.M. Richards Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath J Am Coll Cardiol 42 2003 728 735
9. M. Nakamura, H. Endo, M. Nasu, N. Arakawa, T. Segawa, and K. Hiramori Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese population Heart 87 2002 131 135
10. Y. Hirata, A. Matsumoto, T. Aoyagi, K. Yamaoki, I. Komuro, T. Suzuki, T. Ashida, T. Sugiyama, Y. Hada, I. Kuwajima, M. Nishinaga, H. Akioka, O. Nakajima, R. Nagai, and Y. Yazaki Measurement of plasma brain natriuretic peptide level as a guide for cardiac overload Cardiovasc Res 51 2001 585 591
11. Y. Kiyohara, K. Ueda, and M. Fujishima Smoking and cardiovascular disease in the general population in Japan J Hypertens Suppl 8 1990 S9 S15
12. K.K. Teo, S. Ounpuu, S. Hawken, M.R. Pandey, V. Valentin, D. Hunt, R. Diaz, W. Rashed, R. Freeman, L. Jiang, X. Zhang, and S. Yusuf Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study Lancet 368 2006 647 658
13. M.A. Jonas, J.A. Oates, J.K. Ockene, and C.H. Hennekens Statement on smoking and cardiovascular disease for health care professionals American Heart Association Circulation 86 1992 1664 1669
14. J.A. Ambrose, and R.S. Barua The pathophysiology of cigarette smoking and cardiovascular disease: an update J Am Coll Cardiol 43 2004 1731 1737
15. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, R.O. Cannon III, M. Criqui, Y.Y. Fadl, S.P. Fortmann, Y. Hong, G.L. Myers, N. Rifai, S.C. Smith Jr, K. Taubert, R.P. Tracy, and F. Vinicor Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511
16. R.R. van Kimmenade, J.L. Januzzi Jr, J.A. Bakker, A.J. Houben, R. Rennenberg, A.A. Kroon, H.J. Crijns, M.P. van Dieijen-Visser, P.W. de Leeuw, and Y.M. Pinto Renal clearance of B-type natriuretic peptide and amino terminal proB-type natriuretic peptide: a mechanistic study in hypertensive subjects J Am Coll Cardiol 53 2009 884 890
17. S. Matsuo, E. Imai, M. Horio, Y. Yasuda, K. Tomita, K. Nitta, K. Yamagata, Y. Tomino, H. Yokoyama, and A. Hishida Revised equations for estimated GFR from serum creatinine in Japan Am J Kidney Dis 53 2009 982 992
18. Y. Seino, A. Ogawa, T. Yamashita, M. Fukushima, K. Ogata, H. Fukumoto, and T. Takano Application of NT-proBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure Eur J Heart Fail 6 2004 295 300
19. J. De Sutter, D. De Bacquer, S. Cuypers, J. Delanghe, M. De Buyzere, M. Kornitzer, and G. De Backer Plasma N-terminal pro-brain natriuretic peptide concentration predicts coronary events in men at work: a report from the BELSTRESS study Eur Heart J 26 2005 2644 2649
20. A. Leone, L. Landini Jr, O. Biadi, and A. Balbarini Smoking and cardiovascular system: cellular features of the damage Curr Pharm Des 14 2008 1771 1777
21. R. Celis, G. Torre-Martinez, and G. Torre-Amione Evidence for activation of immune system in heart failure: is there a role for anti-inflammatory therapy? Curr Opin Cardiol 23 2008 254 260
22. H. Iso, C. Date, A. Yamamoto, H. Toyoshima, Y. Watanabe, S. Kikuchi, A. Koizumi, Y. Wada, T. Kondo, Y. Inaba, and A. Tamakoshi Smoking cessation and mortality from cardiovascular disease among Japanese men and women: the JACC Study Am J Epidemiol 161 2005 170 179
23. A. Chiolero, I. Jacot-Sadowski, D. Faeh, F. Paccaud, and J. Cornuz Association of cigarettes smoked daily with obesity in a general adult population Obesity 15 2007 1311 1318
24. U. John, M. Hanke, H.J. Rumpf, and J.R. Thyrian Smoking status, cigarettes per day, and their relationship to overweight and obesity among former and current smokers in a national adult general population sample Int J Obes 29 2005 1289 1294